Brett A. Wall - 01 Aug 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Neuroscience
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
03 Aug 2022, 17:50:39 UTC
Previous filing
02 Aug 2022
Next filing
09 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +7,521 +41% $0.000000 25,646 01 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +18,802 $0.000000 18,802 01 Aug 2022 Performance Share Units 18,802 Direct F2, F3, F4
transaction MDT Stock Option (Right to Buy) Award $0 +59,433 $0.000000 59,433 01 Aug 2022 Ordinary Shares 59,433 $93.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F3 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 18,802 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F4 Vests on August 1, 2025.
F5 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.